Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P5
Near historical low
vs 3Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -21.33% |
| Q3 2025 | 44.05% |
| Q2 2025 | 40.03% |
| Q1 2025 | 9.29% |
| Q4 2024 | 18.90% |
| Q3 2024 | 16.23% |
| Q2 2024 | 30.80% |
| Q1 2024 | -8.18% |
| Q4 2023 | 21.47% |
| Q3 2023 | 15.22% |
| Q2 2023 | -43.51% |
| Q1 2023 | 2.01% |
| Q4 2022 | 99.00% |
| Q3 2022 | -48.17% |
| Q2 2022 | 11.71% |
| Q1 2022 | -15.31% |
| Q4 2021 | -16.08% |
| Q3 2021 | 24.90% |
| Q2 2021 | 15.21% |
| Q1 2021 | -7.01% |
| Q4 2020 | -0.31% |
| Q3 2020 | 5.59% |
| Q2 2020 | 1.38% |
| Q1 2020 | 2.32% |
| Q4 2019 | 5.22% |
| Q3 2019 | -0.75% |
| Q2 2019 | 12.98% |
| Q1 2019 | -9.60% |
| Q4 2018 | 7.53% |
| Q3 2018 | -1.53% |
| Q2 2018 | 7.56% |
| Q1 2018 | -8.88% |
| Q4 2017 | 4.55% |
| Q3 2017 | 3.97% |
| Q2 2017 | 15.41% |
| Q1 2017 | -9.93% |
| Q4 2016 | 9.96% |
| Q3 2016 | 1.90% |
| Q2 2016 | 14.83% |
| Q1 2016 | -4.73% |